AI assistant
Twist Bioscience Corp — Director's Dealing 2018
Oct 30, 2018
31873_dirs_2018-10-30_8c2edadf-df8d-4310-8a68-3dba30734994.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2018-10-30
Reporting Person: Weiss Patrick (VP of Operations)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 54527 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $5.95 | 2025-09-28 | Common Stock (50499) | Direct | |
| Employee Stock Option (right to buy) | $8.82 | 2027-09-28 | Common Stock (100999) | Direct |
Footnotes
F1: The option is immediately exercisable. 25% of the shares subject to the option vest on September 1, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F2: The option is immediately exercisable. 10% of the shares subject to the option vest on September 29, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.